Caspase

CAT # Izina ryibicuruzwa Ibisobanuro
CPD100616 Emricasan Emricasan, uzwi kandi ku izina rya IDN 6556 na PF 03491390, ni inzitizi ya mbere mu cyiciro cya caspase inhibitor mu bigeragezo bivura indwara z’umwijima. Emricasan (IDN-6556) igabanya imvune yumwijima na fibrosis muburyo bwa murine bwa steatohepatitis idafite inzoga. IDN6556 yorohereza marginal mass islet engmentment ya porcine islet autotransplant moderi. IDN-6556 yo mu kanwa irashobora kugabanya ibikorwa bya aminotransferase kubarwayi barwaye hepatite idakira C. PF-03491390 itangwa mu kanwa igumana umwijima igihe kirekire hamwe na sisitemu nkeya, ikagira ingaruka za hepatoprotective kurwanya alfa-fas iterwa n'umwijima muburyo bw'imbeba. .
CPD100615 Q-VD-Oph QVD-OPH, izwi kandi nka Quinoline-Val-Asp-Difluorophenoxymethylketone, ni inzitizi nini ya caspase inhibitor ifite imiti igabanya ubukana. Q-VD-OPh irinda indwara ya neonatal mu mbeba ya P7: uruhare rwuburinganire. Q-VD-OPh ifite ingaruka zo kurwanya leukemia kandi irashobora gukorana na vitamine D igereranya kugirango HPK1 yerekana ibimenyetso muri selile AML. Q-VD-OPh igabanya apoptose iterwa nihungabana kandi igahindura imikorere yimikorere yinyuma yimbeba nyuma yimvune yumugongo
CPD100614 Z-DEVD-FMK Z-DEVD-fmk ni selile-yinjira, idasubirwaho inhibitor ya caspase-3. Caspase-3 ni poroteyine yihariye ya sisitemuine igira uruhare runini muri apoptose.
CPD100613 Z-IETD-FMK MDK4982, izwi kandi nka Z-IETD-FMK, ni imbaraga zikomeye, zinjira mu ngirabuzimafatizo, zidashobora gusubira inyuma za caspase-8 na granzyme B., Caspase-8 Inhibitor II igenzura ibikorwa by’ibinyabuzima bya Caspase-8. MDK4982 ibuza neza virusi ya grippe iterwa na selile ya HeLa. MDK4982 nayo ibuza granzyme B. MDK4982 ifite CAS # 210344-98-2.
CPD100612 Z-VAD-FMK Z-VAD-FMK ni selile-yinjira, idasubirwaho pan-caspase inhibitor. Z-VAD-FMK ibuza gutunganya caspase no kwinjiza apoptose muri selile yibibyimba muri vitro (IC50 = 0.0015 - 5.8 mM).
CPD100611 Belnacasan Belnacasan, izwi kandi ku izina rya VX-765, yagenewe kubuza Caspase, iyo ikaba ari enzyme igenzura ibisekuruza bibiri bya cytokine, IL-1b na IL-18. VX-765 yerekanwe kubuza gufatwa gukabije muburyo bwa preclinical. Mubyongeyeho, VX-765 yerekanye ibikorwa muburyo bwa preclinical epilepsy idakira. VX-765 yari imaze kwipimisha ku barwayi barenga 100 mu cyiciro cya mbere cy’icyiciro cya I n’icyiciro cya IIa kijyanye n’izindi ndwara, harimo n’iminsi 28 y’amavuriro ya IIa ku barwayi barwaye psoriasis. Yasoje icyiciro cyo kuvura icyiciro cya IIa cyamavuriro ya VX-765 yandikishije abarwayi bagera kuri 75 bafite igicuri kitarwanya imiti. Ikigeragezo cya kabiri-gihumye, cyateganijwe, kigenzurwa na platbo cyateguwe hagamijwe gusuzuma umutekano, kwihanganira ibikorwa byubuvuzi bya VX-765.
Ese?

Twandikire

Itohoza

Amakuru agezweho

  • Inzira 7 Zambere Mubushakashatsi bwa Farumasi Muri 2018

    Inzira 7 Zambere Mubushakashatsi bwa Farumasi I ...

    Kuba uri munsi yigitutu cyinshi kugirango duhatane mubibazo bitoroshye byubukungu n’ikoranabuhanga, uruganda rukora imiti n’ibinyabuzima rugomba guhora rushya muri gahunda zabo za R&D kugirango rukomeze imbere ...

  • ARS-1620: Kanseri nshya ya KRAS-mutant

    ARS-1620: Inhibitor nshya itanga ikizere kuri K ...

    Nk’uko ubushakashatsi bwasohotse mu Kagari bubitangaza, abashakashatsi bakoze inzitizi yihariye ya KRASG12C yitwa ARS-1602 itera ibibyimba gusubira mu mbeba. "Ubu bushakashatsi butanga muri vivo ibimenyetso byerekana ko mutant KRAS ishobora kuba ...

  • AstraZeneca yakira imbaraga zo kugenzura imiti ya oncology

    AstraZeneca yakira imbaraga zo kugenzura ...

    Ku wa kabiri, AstraZeneca yakiriye inshuro ebyiri mu nshingano zayo za oncology, nyuma y’uko abagenzuzi b’Amerika n’Uburayi bemeye gutanga amabwiriza agenga imiti y’ibiyobyabwenge, intambwe yambere yo gutsindira kwemerwa niyi miti. ...

Ikiganiro cya WhatsApp Kumurongo!